Novel Ionizable Lipid Nanoparticles for SARS‐CoV‐2 Omicron mRNA Delivery (Adv. Healthcare Mater. 13/2023)
Advanced Healthcare Materials(2023)
Abstract
Ionizable Lipid Nanoparticles Lipid nanoparticle (LNP) systems are currently the leading nonviral delivery systems for enabling the clinical potential of mRNA drugs. Ionizable lipid is the critical component of lipid nanoparticles. In article 2202590 by Gengshen Song, Jing Yang, Shengqi Wang, and co-workers, a novel ionizable lipid YK009 is designed and developed for LNP formulation. The YK009-LNP shows high mRNA delivery efficacy and good safety. An mRNA vaccine against the SARS-CoV-2 Omicron variant delivered by YK009-LNP can trigger a robust immune response against this viral infection.
MoreTranslated text
Key words
nanoparticles
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined